TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024

Rhea-AI Summary

TransMedics Group, Inc. will announce its first-quarter 2024 financial results on April 30, 2024. The company specializes in medical technology for organ transplant therapy, focusing on patients with end-stage lung, heart, and liver failure.

ANDOVER, Mass., April 16, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the first quarter 2024 after market close on Tuesday, April 30, 2024. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (866) 807-9684 for domestic callers or (412) 317-5415 for international callers and ask to be joined into the TransMedics call. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-first-quarter-2024-financial-results-on-april-30-2024-302118594.html

SOURCE TransMedics Group, Inc.

When will TransMedics report its first-quarter 2024 financial results?

TransMedics will report its first-quarter 2024 financial results on April 30, 2024.

What does TransMedics specialize in?

TransMedics specializes in medical technology for organ transplant therapy, specifically for patients with end-stage lung, heart, and liver failure.

How can investors listen to the conference call?

Investors can listen to the conference call by dialing (866) 807-9684 for domestic callers or (412) 317-5415 for international callers and asking to be joined into the TransMedics call.

Where can investors access the live and archived webcast of the event?

Investors can access the live and archived webcast of the event on the 'Investors' section of the TransMedics website at https://investors.transmedics.com/.